These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The association of homocysteine and coronary artery disease. Gauthier GM; Keevil JG; McBride PE Clin Cardiol; 2003 Dec; 26(12):563-8. PubMed ID: 14677809 [TBL] [Abstract][Full Text] [Related]
3. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care. Booth GL; Wang EE CMAJ; 2000 Jul; 163(1):21-9. PubMed ID: 10920726 [TBL] [Abstract][Full Text] [Related]
4. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations. Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M; Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016 [TBL] [Abstract][Full Text] [Related]
5. [Homocysteine and coronary artery disease]. Aro A Duodecim; 2003; 119(12):1131-5. PubMed ID: 12868359 [No Abstract] [Full Text] [Related]
10. Homocysteine, B vitamins, and coronary artery disease. Seshadri N; Robinson K Med Clin North Am; 2000 Jan; 84(1):215-37, x. PubMed ID: 10685136 [TBL] [Abstract][Full Text] [Related]
11. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases. Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738 [TBL] [Abstract][Full Text] [Related]
14. [Hyperhomocysteinemia in pediatric age and nutritional aspects of folates: an early cardiovascular risk factor]. Caramia G; Belardinelli R Monaldi Arch Chest Dis; 2006 Dec; 66(4):275-85. PubMed ID: 17312847 [TBL] [Abstract][Full Text] [Related]
15. A novel approach in the management of hyperhomocysteinemia. Qureshi SS; Gupta JK; Goyal A; Narayan Yadav H Med Hypotheses; 2019 Aug; 129():109245. PubMed ID: 31371071 [TBL] [Abstract][Full Text] [Related]
16. [Hyperhomocysteinemia. A new coronary risk factor]. Zacarías-Castillo R; Hernández-Rebollar AE; Zajarias-Rabchinskey A; González-Bárcena D Gac Med Mex; 2001; 137(4):335-45. PubMed ID: 11519357 [TBL] [Abstract][Full Text] [Related]
17. Homocysteine: the latest risk factor for heart disease. Reeder SJ; Hoffmann RL; Magdic KS; Rodgers JM Dimens Crit Care Nurs; 2000; 19(1):22-8. PubMed ID: 10876482 [TBL] [Abstract][Full Text] [Related]
18. Changes of homocysteine levels and arterial endothelial function in patients with high risk of coronary artery disease after 6-month folic acid supplementation. Guo H; Lee JD; Xing Y; Cheng J; Ueda T; Toyoda K; Geshi T Acta Cardiol; 2004 Oct; 59(5):503-6. PubMed ID: 15529554 [TBL] [Abstract][Full Text] [Related]
19. Hyperhomocysteinaemia & folic acid supplementation in patients with high risk of coronary artery disease. Guo H; Lee JD; Ueda T; Cheng J; Shan J; Wang J Indian J Med Res; 2004 Jan; 119(1):33-7. PubMed ID: 14997992 [TBL] [Abstract][Full Text] [Related]
20. Hyperhomocysteinaemia and cardiovascular risk in female ovariectomized rats: role of folic acid and hormone replacement therapy. el-Swefy SE; Ali SI; Asker ME; Mohamed HE J Pharm Pharmacol; 2002 Mar; 54(3):391-7. PubMed ID: 11902805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]